The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast CancerMartin Filipits, Torsten O. Nielsen, Margaretha Rudas et al.|Clinical Cancer Research|2014Cited by 219
Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal CancerShuzhen Liu, Lei Lei, Qing Cao et al.|International Journal of Molecular Sciences|2020Cited by 69
Construction of a metastasis-associated ceRNA network reveals a prognostic signature in lung cancerQing Cao, Lei Lei, Bianbian Yan et al.|Cancer Cell International|2020Cited by 44
Supplementary Table 1 from The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast CancerMartin Filipits, Michael Gnant, Torsten O. Nielsen et al.|Unknown|2023Cited by 0